Gastric And Duodenal Antiulcer Activity Of Alkaloids: A Review by Falcao H.D.S. et al.








Gastric and Duodenal Antiulcer Activity of Alkaloids: A Review 
 
Heloina de Sousa Falcão 1, Jacqueline Alves Leite 1, José Maria Barbosa-Filho 1, Petrônio 
Filgueiras de Athayde-Filho 1, Maria Célia de Oliveira Chaves 1, Marcelo Dantas Moura 1, 
Anderson Luiz Ferreira 2, Ana Beatriz Albino de Almeida 2, Alba Regina Monteiro Souza-Brito2, 
Margareth de Fátima Formiga Melo Diniz 1 and Leônia Maria Batista 1,*  
 
1  Laboratório de Tecnologia Farmacêutica, Universidade Federal da Paraíba - UFPB, Cx. Postal 
5009, 58051-970, João Pessoa, PB, Brazil; E-mail: heloinafalcao@yahoo.com.br (H. S-F.),  
jacq_pet@hotmail.com (J-A. L.),  jbarbosa@ltf.ufpb.br (J-M. B-F.), 
athayde_filho@pesquisador.cnpq.br(F. A-F.),  cchaves@ltf.ufpb.br (M-C. O-C.), 
tetelodantas@bol.com.br (M-D. M.), margareth@ccs.ufpb.br (M. F-F.), leoniab@uol.com.br (L-M. 
B.) 
2  Laboratório de Produtos Naturais, Universidade Estadual de Campinas - UNICAMP, Cx. Postal 
6109, 13083-970, Campinas, SP, Brazil; E-mails: domcarecone@yahoo.com.br (A-L. F.), 
anabia5@yahoo.com.br (A-A. A.), abrito@unicamp.br (A-M. S-B.) 
 
*  Author to whom correspondence should be addressed; E-mail: leoniab@uol.com.br.  
Received: 30 July 2008; in revised form: 7 November 2008 / Accepted: 2 December 2008 / Published: 
17 December 2008  
 
 
Abstract: Peptic ulcer disease is a deep gastrointestinal erosion disorder that involves the 
entire mucosal thickness and can even penetrate the muscular mucosa. Numerous natural 
products have been evaluated as therapeutics for the treatment of a variety of diseases, 
including this one. These products usually derive from plant and animal sources that contain 
active constituents such as alkaloids, flavonoids, terpenoids, tannins and others. The 
alkaloids are natural nitrogen-containing secondary metabolites mostly derived from amino 
acids and found in about 20% of plants. There has been considerable pharmacological 
research into the antiulcer activity of these compounds. In this work we review the literature 
on alkaloids with antiulcer activity, which covers about sixty-one alkaloids, fifty-five of 
which have activity against this disease when induced in animals. 
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For over a century, peptic ulcer disease has been one of the leading causes of gastrointestinal 
surgery, with high morbidity and mortality rates. The prevalence of gastrointestinal ulcers differs 
around the world: duodenal ulcers are dominant the Western populations and gastric ulcers are more 
frequent in Asia, especially in Japan. As the prevalence of this disease increases over time, one would 
expect peptic ulcers to continue to have a significant global impact in the basic health and economic 
systems and in patients' life quality [1]. 
Peptic ulcers are a deep gastrointestinal erosion disorder that involves the entire mucosal thickness, 
penetrating the muscular mucosa [2]. For decades it was believed that gastrointestinal ulcerations were 
caused by the excessive secretion of gastric acid, but many patients presenting such ulcerations had 
normal acid secretion rates [3]. Then, researchers reported that peptic ulcers were been caused by an 
imbalance between the aggressive factors and a number of known defense mechanisms. Exogenous 
aggressive factors such as smoke, anti-inflammatory drugs, alcohol, stress, fatty foods and 
Helicobacter pylori infections triggered tissue necrosis through mucosal ischemia, free radical 
generation and cessation of nutrient delivery, hydrochloric acid together with pepsin, pancreatic 
enzymes and bile decreased the defense mechanisms of gastrointestinal mucosa such as the 
intercellular junctions, local blood flow, mucus/bicarbonate secretion and cellular growth [2, 4, 5]. 
In recent years, a large advance in chemical and pharmacological studies has contributed to the 
knowledge about new therapeutically active compounds obtained from the natural products [6]. These 
compounds can be used directly as leads for the development of new medicines or as pharmacological 
tools to discover new active compounds, so they can be life-saving or determine the quality of life in 
long-lasting diseases [7, 8]. However, the incorrect use of the natural products offers dangers to 
society, so it is important to identify the active compounds, linking its structure with the biological 
activity and report the correct manner to use them with regards to dose, route of administration and 
frequency of use [9]. 
The natural active compounds classes or secondary metabolites as alkaloids, flavonoids, terpenoids, 
tannins and others have attracted researchers to investigate their chemical, toxicological and 
pharmacological features. The alkaloids represent a group of natural products that has had a major 
impact throughout history on the economic, medical, political and social affairs of humans. They are a 
diverse group of low molecular weight nitrogen-containing compounds derived mostly from amino 
acids [10]. These secondary metabolites are found in about 20 % of plant species and they classified as 
true alkaloids, which have nitrogen atoms in heterocyclic rings, protoalkaloids, which do not have the 
nitrogen atom(s) in heterocyclic rings and pseudoalkaloids, which don’t derive from amino acids but 
may have nitrogen atoms in heterocyclic rings [11]. 
Several alkaloids are being used in therapeutics and as pharmacological tools. A wide range of 
biological activities of alkaloids have been reported: emetic, anti-cholinergic, antitumor, diuretic, 
sympathomimetic, antiviral, antihypertensive, hypnoanalgesic, antidepressant, miorelaxant, 
antitussigen, antimicrobial and anti-inflammatory [11]. However, the alkaloids and other natural 
compounds have complex activities and it is necessary to analyze pharmacological activities in the 




general tissues, linking the structure with the activity presented. It is common to find pharmacological 
results where a single experimental model generalizes a biological answer, but these can’t be accepted 
because all the pathologies in question are also complex and it is necessary to investigate specific 
experimental models.  
In the course of our continuing search for bioactive natural products from plants, we have recently 
published reviews on crude plant extracts and plant-derived compounds with the following potential 
activities and uses: as inhibitors of mammary, uterine cervical and ovarian neoplasia [12-14]; as 
inhibitors of HMG CoA reductase [15]; with central analgesic activity [16]; employed in prevention of 
osteoporosis [17]; for the treatment of Parkinson’s disease [18]; antileishmanial, hypoglycemic and 
anti-inflammatory activities [19-22]; as inhibitors of the acetylcholinesterase enzyme [23], inhibitors 
of the angiotensin-converting enzymes [24], with giardicidal and antileprotic activities [25, 26] and 
plant extracts with antiulcer activity [27]. 
In this article, we have reviewed some reports about alkaloids with antiulcer activity in the 
specialized literature pubished up to December 2007. The search was carried out on data banks such as 
SciFinder Scholar, Periódicos CAPES, Pubmed and NAPRALERT (acronym for Natural Products 
ALERT - University of Illinois in Chicago, U.S.A.). The references were consulted for details of the 
experimental models used for testing the alkaloids against peptic ulcer, activities, route of 
administration, organism tested and subtypes of alkaloids studied. 
 
Alkaloids studied in models that investigate the antiulcer activity  
  
For this review we identified sixty-one alkaloids studied in models that evaluate the antiulcer 
activity and distributed among thirteen subtypes: imidazole, indole, isoquinoline, non-nitrogen 
heterocycle alkaloid, phenylalkylamide, piperidine, pyrazine, pyridine, pyrrolidine, pyrrolizidine, 
quinolizidine, steroid and tropane alkaloids. Fifty-five of these alkaloids have reported antiulcer 
activity (see Table 1). 
Among the different alkaloids showing potent pharmacological properties are the narcotic analgesic 
morphine, the antimicrobial berberine and the sympathomimetic ephedrine. These isoquinoline 
alkaloids occur mainly in the Papaveraceae, Berberidaceae and Ephedraceae families [10]. The 
compounds morphine and ephedrine also have confirmed antiulcer activity, inhibiting gastric lesions 
induced by reserpine, aspirin or indomethacin [28, 29]. Berberine didn’t display this activity towards 
ethanol induced ulcers [30-32], but 7,8-dihydro-8-hydroxypalmatine, a new type of protoberberine 
alkaloid obtained from the bark of Enantia chlorantha, accelerated ulcer-healing and increased the 
gastric mucus production after the lesions have been caused by acetic acid, HCl/ethanol or absolute 
ethanol and it also has been investigated in the pylorus ligature model [33, 34]. Other isoquinoline 
alkaloids isolated from Coptidis rhizome, coptisine and 8-oxocoptisine, showed protection of gastric 
mucosa similar to that offered by gastroprotective medicines such as cimetidine and sucralfate [30, 35, 
36]. 
Tropane alkaloids are dicyclic compounds formed by condensation of a pyrrolidine precursor amino 
acid (ornithine) with three acetate-derived carbon atoms. Some of these alkaloids such as atropine and 
scopolamine constitute an important class of anticholinergic compounds derived from plants that occur 
in several Atropa and Datura species [10]. Clinically, they are used to block the muscarinic activity of 




acetylcholine showing antispasmodic and antisecretory effects in the treatment of spastic colitis, 
gastroenteritis and peptic ulcer. They also are useful pharmacological tools to discover new active 
principles with gastrointestinal tract actions [37-40]. Anisodamine and anisodine are analogs of 
atropine and they were evaluated as protectors of gastric mucosa against the damaging effects induced 
in rats by indomethacin, reserpine, stress, pylorus ligature, acetic acid or absolute ethanol. In this 
research, these compounds inhibited the lesions caused by aggressor agents and altered the gastric acid 
secretion through increase of luminal gastric output of basal bicarbonate and pH [39, 41-43]. Another 
well known tropane alkaloid, cocaine, showed antiulcer activity against ulcers induced by reserpine in 
rats when it was used in the dose of 10 mg/kg by oral route of administration [29]. This substance is 
obtained of the Erythroxylum coca leaves and has multiple actions in the central and peripheral 
nervous system. It is a psychomotor stimulant with a strong abuse potential and has ability to dominate 
or decreasing behaviors such as eating and sleeping. 
A pyridine alkaloid well known in society is nicotine, which is found in the Solanaceae family, 
mainly in the dried leaves of the tobacco plant Nicotiana tabacum Linné. This substance acts on the 
nicotinic receptors of acetylcholine in autonomic ganglia, adrenal medulla, neuromuscular junction 
and brain of mammals. The chronic use of nicotine may result in psychologic and physical 
dependence. However, this alkaloid protected the stomach from damage induced by aspirin by 
decreasing hemorrhages and increasing the pH gradient/gastric fluid volume [44]. 
Quinolizidine alkaloids such as matrine, 13-alpha-hydroxymatrine and oxy-matrine were isolated 
from Sophora flavescens (Fabaceae) and they were experimentally tested for inhibition of gastric 
ulcers induced by pylorus ligature, water immersion stress and indomethacin. These alkaloids 
decreased the acid secretion and inhibited the gastric motility [45-49]. 
  A piperidine alkaloid is piperine, which has a pungent taste and was studied in connection with 
the gastric mucosa damage caused by stress, indomethacin, ethanol or pylorus ligature in rats or mice. 
This substance protected the stomach against ulceration by decreasing the volume of gastric juice, 
gastric acidity and pepsin-A activity in doses of 1.5 mg/kg and 25 mg/kg after intravenous and oral 
administrations, respectively [50, 51]. Capsaicin is a phenylakylamide alkaloid and it also has a 
pungent taste. This substance provides a selective probe for mechanisms involving slowly conducting 
primary afferent neurons. In the stomach, capsaicin (0.3 nanolmol/kg - 10 mg/kg) stimulates these 
neurons and signalizes for protection inhibiting the acid secretion, stimulating the alkali/mucus 
secretions and mainly increasing the gastric mucosal blood flow which help in prevention and healing 
of ulcers against injury caused by aggressive agents. However, neurotoxic doses of capsaicin have 
augmented the susceptibility of gastric mucosa to injury caused by strong irritants [52, 53]. 
 Steroidal alkaloids have been found in the Apocynaceae, Buxaceae, Liliaceae and Solanaceae 
families. In this review, pachystermine A, pachysamine A, epipachysamine A, pachysandrine A and 
spiropachysine obtained from Pachysandra terminalis (Buxaceae), used in Ainu folk medicine for 
gastrointestinal diseases, were investigated for their preventive effects on gastric lesions induced by 
water-immersion stress in mice and the results this evaluation suggested that these alkaloids may 
contribute partly to the traditional use of the plants for the gastrointestinal complaints [54]. 
An important class of alkaloid is the indole constituted by melatonin, cantinone, hirsuteine, 
reserpine, lysergic acid (LSD), yohimbine and nigakinone. Melatonin has been found in algae and 
humans. This human hormone is secreted by pineal gland and gastrointestinal cells. Moreover, it has 




antiulcer activity because showed to protect the gastric mucosa from the damage caused by ischemia-
reperfusion and absolute ethanol through of the attenuation of the gastric blood flow failed and 
scavenging of free radicals [55]. Reserpine was isolated of Rauvolfia serpentina (Apocynaceae) and 
didn’t show antiulcer effect in the dose of 2.5 mg/kg when the gastric ulcers were induced by stress in 
mice [46], while yohimbine, obtained of Pausinystalia yohimbe (Rubiaceae), was active in the 
reduction of gastrointestinal ulceration [56]. Other alkaloids such as hirsutine, hirsuteine, and 
rhynchophylline isolated from the domestic plant Uncaria rhynchophylla Miq. showed mild central 
depressive, anti-spasmodic and hypotensive effects in mice or rats. These substances also were 
effective in the dose of 60 mg/kg against gastric lesions, while isorhynchophylline didn´t have a 
preventive effect on the development of gastric erosions in mice [56]. Nigakinone and 
methylnigakinone are also indole alkaloids and they can be found in Picrasma quassioides, P. 
ailanthoides or Ailanthus altissima. These substances had antiulcer effects associated with decreases in 
gastric acid/pepsin secretions and protection of the mucous membrane [57, 58]. Cantin-6-one and 4-
methoxycantinone are alkaloids extracted from Simaroubaceae plants. These substances were found in 
Quassia amara, Simaba multiflora, S. polyphylla, S. feruginea and Eurycoma longifolia which are 
popularly indicated for gastrointestinal disorders, obesity, anti-inflammatory, stimulant of the intestinal 
motility and central nervous system activities. These compounds were effective against gastric lesions 
induced by ethanol and indomethacin [59]. 
The pyrrolizidine alkaloids integerrimine, retrorsine, senecionine, usaramine and seneciphylline 
were extracted from Senecio brasiliensis. These alkaloids demonstrate significant activity in acute and 
chronic gastric ulcers in the dose of 12.5 mg/kg. These alkaloids increased free mucus and 
prostaglandin in the mucosal gastric. Moreover, they showed a reduction of exfoliation of superficial 
cells, hemorrhages and blood cell infiltration that can be mediated by increase in gastrin secretion and 
mRNA expression of epidermal growth factors [60]. 
 
Table 1. Alkaloids with gastrointestinal antiulcer activity 
Substance 
Experimental models/dose – 
Route of administration 
Organism tested Effect 
Imidazole alkaloids    
Allantoin Phenylbutazone induced  ulcer/ 
6 g/kg – gastric intubation 
Rat Active [61] 





















Table 1. Cont. 
Substance Experimental models/dose 
- Route of administration 







50% ethanol induced gastric 
ulcer/2.5; 10 and 20 mg/kg – oral 
and intraperitoneal 







50% ethanol induced gastric ulcer/ 
10 and 20 mg/kg – oral and 
intraperitoneal 


































5-HT induced gastric 
ulcers/30mg/kg – intramuscular 
Guinea pig Active [64] 




























Table 1. Cont. 
Substance  
Experimental models/ 
Route of administration 
Organism tested Effect 








Pylorus-ligated induced ulcer/ 
31.3 mg/kg - * 









Pylorus-ligated induced ulcer/ 
62.5 mg/kg - * 
Rat Active [58] 
Reserpine Stress induced ulcer/2.5 mg/kg – 
subcutaneous 








































*/60 mg/kg – intraperitoneal Mouse Inactive [56] 




Table 1. Cont. 
Substance 
Experimental models/ 
Route of administration 


































*/20 mg/kg – intraperitoneal Mouse Active [56] 
Isoquinoline alkaloids    
Berberine Ethanol induced gastric ulcer/ 
25 mg/kg – intragastric 









*/15 mg/kg – gastric intubation Rat Weak activity [31] 
Pylorus-ligated induced ulcer/ 
10 mg/kg – oral 






OMe O  
Ethanol induced gastric ulcer/ 
50 mg/day - intragastric 
Rat Inactive [30] 
 




Table 1. Cont. 
Substance 
Experimental models/ 
Route of administration 







*/intragastric Rat Active [66] 
Cathinone, (-) Aspirin induced gasric ulcer/ 
10 mg/kg - intragastric 
Rat Active [28] 
 Indomethacin induced gastric 
ulcer/10 mg/kg - intragastric 
Rat Active [28] 
Phenylbutazone induced gastric 
ulcer/10 mg/kg - intragastric 
Rat Active [28] 
Cathinone, (+) Aspirin induced gasric ulcer/ 
10 mg/kg - intragastric 
Rat Active [28] 
 
Indomethacin induced gastric 
ulcer/10 mg/kg - intragastric 
Rat Active [28] 
Phenylbutazone induced gastric 
ulcer/10 mg/kg - intragastric 
Rat Active [28] 
Coptisine Ethanol induced gastric ulcer/ 








80% ethanol induced ulcer/ 
0.1 mg/kg - intragastric Rat Active [35] 
80% ethanol induced ulcer/ 
0.1 mg/kg - intragastric 
Rat Active [36] 
Coptisine, 8-oxo Ethanol induced gastric ulcer/ 
0.1 mg/kg - intragastric 









80% ethanol induced ulcers/ 
0.1 mg/kg - intragastric 










*/15 mg/kg - oral Human adult Active [67] 




Table 1. Cont. 
Substance 
Experimental models/ 
Route of administration 
Organism tested Effect 










*/* Bullfrog Active [68] 
Pylorus-ligated induced gastric 
ulcer/oral 
Rat Active [69] 
Stress induced gastric ulcer/oral Rat Active [69] 
Pylorus-ligated induced gastric 
ulcer/subcutaneous 
Rat Active [69] 
Stress induced gastric ulcer/ 
subcutaneous 
Rat Active [69]  
Histamine induced ulcers of 
duodenum/oral 
Guinea pig Active [69] 
Histamine induced ulcers of 
duodenum/subcutaneous 
Guinea pig Inactive [69] 
Reserpine induced gastric ulcer/ 
oral 
Rat Active [69] 
Reserpine induced gastric ulcer/ 
subcutaneous 






















*/* * Active [71] 
Ephedrine, nor-n-formyl (-) Aspirin induced ulcers/5 mg/kg - 
intragastric 







Indomethacin induced ulcers/ 
10 mg/kg - intragastric 
Rat Active [28] 




Table 1. Cont. 
Substance 
Experimental models/ 
Route of administration 
Organism tested Effect 






Aspirin induced ulcers/5 mg/kg - 
intragastric 
Rat Active [28] 
Glaziovine Histamine induced ulcers/ 
5 mg/kg - intraperitoneal 






Reserpine induced ulcers/ 
5 mg/kg - intraperitoneal 
Rat Active [72] 
Serotonin induced ulcers/ 
5 mg/kg - intraperitoneal 
Rat Active [72] 
Restraint stress induced ulcers/ 
5 mg/kg - intraperitoneal 
Rat Active [72] 
Pylorus-ligated induced ulcers/ 
5 mg/kg - intraperitoneal 
Rat Active [72] 











Reserpine induced ulcers/ 
10 mg/kg - oral 
Rat Active [29] 
Palmatine, 7-8-dihydro: 8-hydroxy Ethanol induced gastric ulcers/ 
50 mg/kg - intragastric 








Pylorus-ligated induced ulcers/ 
50 mg/kg - intragastric 
Rat Active [33] 
Acetic acid induced ulcers/ 
80 mg/kg - intragastric 
Rat Active [33] 
*/100 mg/kg - intragastric Rat Active [34] 
Non- nitrogen heterocycle alkaloid 
Chlorophyll  Pylorus-ligated induced ulcers/ 
1 g/kg - intravenous 



















Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
Phenylalkylamide alkaloid    
Capsaicin Ethanol induced gastric ulcer/ 
0.3 nanomol/kg - intragastric 







80% ethanol induced ulcer/ 
2 mg/kg - intragastric 
Rat Active [75] 
80% ethanol induced ulcer/ 
2 mg/kg - subcutaneous 
Rat Active [75] 
Pylorus-ligated induced ulcer/ 
1 μg/kg - intragastric 
Rat Active [76] 
Aspirin induced ulcer/0.6 μg/kg - 
intragastric 
Rat Active [77] 
Ethanol induced ulcer/ 
0.105 μg/kg - intragastric Rat Active [77] 
HCl induced ulcer/0.1 μg/kg - 
intragastric Rat Active [77] 
Acetic acid induced ulcer/ 
10 mg/kg - intragastric Rat Active [78] 
*/0.5 mg/kg - intragastric Rat Active [53] 
Piperidine alkaloid    
Piperine Aspirin induced ulcer/1,5 mg/kg - 
intravenous 








Restraint stress induced ulcer/ 
25 mg/kg - intragastric 
Rat Active [51] 
Indomethacin induced ulcer/ 
25 mg/kg - intragastric 
Rat Active [51] 
HCl/ethanol induced gastric ulcer/25 
mg/kg - intragastric 
Rat Active [51] 
Pylorus-ligated induced ulcer/ 
25 mg/kg - intragastric 
Rat Active [51] 
Restraint stress induced ulcer/ 
25 mg/kg - intragastric 
Mouse Active [51] 
Indomethacin induced ulcer/ 
25 mg/kg - intragastric 
Mouse Active [51] 
HCl/ethanol induced gastric ulcer/25 
mg/kg - intragastric 
Mouse Active [51] 
Pylorus-ligated induced ulcer/ 
25 mg/kg – intragastric 
 
Mouse Active [51] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
Pyrazine alkaloid    
Ligustrazine 
 
Water-immersion stress induced 
ulcer/intragastric 










Restraint stress induced ulcer/ 
intragastric 
Rat Active [79] 
   
Pyridine alkaloids    
Gentianine Pylorus-ligated induced ulcers/ 
100 mg/kg - oral 







ulcers/100 mg/kg - oral 
Rat Active [80] 








Stress induced gastric ulcer/ 
300 mg/kg - subcutaneous 







Aspirin induced ulcer/ 
1mg/animal - intragastric 
Rat Active [44] 








*/* Rat Active [82] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
Pyrrolizidine alkaloids    
Interregimine Hypothermic restraint stress induced 
gastric ulcer/12.5 mg/kg of crude 
alkaloid extract - oral 













Ethanol induced gastric ulcer/ 
12.5 mg/kg of crude alkaloid extract 
- oral 
Rat Active [60] 
Cysteamine induced duodenal 
ulcer/12.5 mg/kg of crude alkaloid 
extract - oral 
Rat Active [60] 
Indomethacin induced gastric 
ulcer/12.5 mg/kg of crude alkaloid 


















Hypothermic restraint stress induced 
gastric ulcer/12.5 mg/kg of crude 
alkaloid extract - oral 
Mouse Active [60] 
Ethanol induced gastric ulcer/ 
12.5 mg/kg of crude alkaloid extract 
- oral 
Rat Active [60] 
Cysteamine induced duodenal 
ulcer/12.5 mg/kg of crude alkaloid 
extract - oral 
Rat Active [60] 
Indomethacin induced gastric 
ulcer/12.5 mg/kg of crude alkaloid 


















Hypothermic restraint stress induced 
gastric ulcer/12.5 mg/kg of crude 
alkaloid extract – oral 
Mouse Active [60] 
Ethanol induced gastric ulcer/ 
12.5 mg/kg of crude alkaloid extract 
- oral 
Rat Active [60] 
Cysteamine induced duodenal 
ulcer/12.5 mg/kg of crude alkaloid 
extract - oral 
Rat Active [60] 
Indomethacin induced gastric 
ulcer/12.5 mg/kg of crude alkaloid 









Table 1. Cont. 
Substance 
Experimental models/ 
Route of administration 















Hypothermic restraint stress induced 
gastric ulcer/12.5 mg/kg of crude 
alkaloid extract - oral 
Mouse Active [60] 
Ethanol induced gastric ulcer/ 
12.5 mg/kg of crude alkaloid extract 
- oral 
Rat Active [60] 
Cysteamine induced duodenal 
ulcer/12.5 mg/kg of crude alkaloid 
extract - oral 
Rat Active [60] 
Indomethacin induced gastric 
ulcer/12.5 mg/kg of crude alkaloid 



















Hypothermic restraint stress induced 
gastric ulcer/12.5 mg/kg of crude 
alkaloid extract - oral 
Mouse Active [60] 
Ethanol induced gastric ulcer/ 
12.5 mg/kg of crude alkaloid extract 
- oral 
Rat Active [60] 
Cysteamine induced duodenal 
ulcer/12.5 mg/kg of crude alkaloid 
extract - oral 
Rat Active [60] 
Indomethacin induced gastric 
ulcer/12.5 mg/kg of crude alkaloid 




Quinolizidine alkaloids    
Matrine Water-immersion stress induced 
ulcers/25 mg/kg - gastric intubation 












Restraint stress induced ulcers/ 
25 mg/kg - gastric intubation 
Mouse Active [45] 
Water-immersion stress induced 
ulcers/10 mg/kg - intraperitoneal 
Mouse Weak activity [45] 
Restraint stress induced ulcers/ 
10 mg/kg - intraperitoneal 
Mouse Weak activity [45] 
Water-immersion stress induced 
ulcers/10 mg/kg - intravenous 
Mouse Active [45] 
Restraint stress induced ulcers/ 
10 mg/kg – intravenous 
 
Mouse Active [45] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
 Stress induced ulcer/50 mg/kg - 
gastric intubation 
Mouse Active [46] 
Stress induced ulcer/50 mg/kg - 
Intraperitoneal 
Mouse Active [46] 
Restraint stress induced ulcers/ 
50 mg/kg - gastric intubation 
Mouse Active [47] 
Restraint stress induced ulcers/ 
50 mg/kg - intraperitoneal 
Mouse Weak activity [47] 
Restraint stress induced ulcers/ 
50 mg/kg – intravenous 
Mouse Active [47] 
Pylorus-ligated induced ulcers/ 
50 mg/kg - intraduodenal 
Rat Inactive [45] 
Indomethacin induced ulcers/ 
100 mg/kg - gastric intubation 
Mouse Inactive [45] 
Reserpine induced ulcers/  
50 mg/kg – gastric intubation 
Mouse Active [45] 
Reserpine induced ulcers/ 
25 mg/kg - intravenous 
Mouse Active [45] 
Matrine, 13-alpha-hydroxy Water-immersion stress induced 
ulcers/* - intragastric 










Indomethacin plus alcohol induced 
gastric ulcers/ * -intragastric 
Rat Active [48] 












Indomethacin induced ulcers/*  * Active [49] 
Restraint stress induced ulcers/ * - 
intraduodenal 
Rat Active [49] 
Water-immersion stress induced 
ulcers/25mg/kg - gastric intubation 
Mouse Active [45] 
Restraint stress induced ulcers/ 
25 mg/kg - gastric intubation 
Mouse Active [45] 
Water-immersion stress induced 
ulcers/10 mg/kg - intraperitoneal 
Mouse Active [45] 
Restraint stress induced ulcers/ 
10 mg/kg – intraperitoneal 
 
Mouse Active [45] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
 Water-immersion stress induced 
ulcers/10 mg/kg - intravenous 
Mouse Weak activity [45] 
Restraint stress induced ulcers/ 
10 mg/kg - intravenous 
Mouse Weak activity [45] 
Stress induced ulcer/50 mg/kg - 
gastric intubation 
Mouse Active [46] 
Stress induced ulcer/50 mg/kg - 
intraperitoneal 
Mouse Active [46] 
Restraint stress induced ulcers/ 
50 mg/kg - gastric intubation 
Mouse Active [47] 
Restraint stress induced ulcers/ 
50 mg/kg - intraperitoneal 
Mouse Active [47] 
Restraint stress induced ulcers/ 
50 mg/kg - intravenous 
Mouse Weak activity [47] 
Indomethacin induced ulcers/ 
100 mg/kg - gastric intubation 
Mouse Active [45] 
Reserpine induced ulcers/ 
50 mg/kg - gastric intubation 
Mouse Active [45] 
Reserpine induced ulcers/ 
50 mg/kg - intravenous 
Mouse Inactive [45] 
Pylorus-ligated induced ulcers/* - 
gastric intubation 
Rat Active [84] 
Steroid alkaloids    
Pachysamine A, epi Water-immersion stress induced 
ulcers/50 mg/kg - intraperitoneal 











Restraint stress induced ulcers/ 
50 mg/kg – intraperitoneal 















Water-immersion stress induced 
ulcers/50 mg/kg - intraperitoneal 
Mouse Active [54] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
Pachystermine A Restraint stress induced ulcers/ 
50 mg/kg - intraperitoneal 
Mouse Active [54] 
 Water-immersion stress induced 
ulcers/50 mg/kg - intraperitoneal 


















Spiropachysine Water-immersion stress induced 
ulcers/50 mg/kg - intraperitoneal 














Restraint stress induced ulcers/ 
50 mg/kg - intraperitoneal 
Mouse Active [54] 
Tropane alkaloids    
Anisodamine Water-immersion stress induced 
ulcers/10 mg/kg – intraperitoneal 











Reserpine induced ulcers/ 
1.5 mg/kg - intraperitoneal 
Rat Active [42] 
Cold stress induced ulcers/ 
2.5 mg/kg - intraperitoneal 
Rat Active [39] 
Indomethacin induced ulcers/ 
0.5 mg/kg - intraperitoneal 
Rat Active [39] 
Acetic acid induced ulcers/ 
10 mg/kg - intraperitoneal 
Rat Active [39] 
Ethanol induced ulcers/25 mg/kg 
- intragastric 
Rat Active [43] 
Indomethacin induced ulcers/ 
25 mg/kg - intragastric 
Rat Active [43] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
 Restraint stress induced ulcers/ 
25 mg/kg - intragastric 
Rat Active [43] 
Pylorus-ligated induced ulcers/ 
25 mg/kg - intragastric 
Rat Active [43] 
Reserpine induced ulcers/ 
1.5 mg/kg - intraperitoneal 
Rat Active [42] 
Anisodine Cold stress induced ulcers/ 
2 mg/kg - intraperitoneal 








Indomethacin induced ulcers/ 
8 mg/kg - intraperitoneal 
Rat Active [39] 
Acetic acid induced ulcers/ 
32 mg/kg  - intraperitoneal 
Rat Active [39] 
Atropine Pylorus-ligated induced ulcers/ 
10 mg/kg - intragastric 









Pylorus-ligated induced ulcers/ 
10 mg/kg - gastric intubation 
Rat Active [38] 
Aspirin induced ulcers/10 mg/kg - 
gastric intubation 









Reserpine induced ulcers/ 
10 mg/kg - oral 
Rat Active [29] 
Scopolamine Cold stress induced ulcers/ 
0.5 mg/kg - intraperitoneal 






Indomethacin induced ulcers/ 
1 mg/kg - intraperitoneal 
Rat Active [39] 
Acetic acid induced ulcers/ 
8 mg/kg – intraperitoneal 
 












ulcers/2.5 mg/kg - subcutaneous 
Rat Active [40] 




Table 1. Cont. 
Substance Experimental models/ 
Route of administration 
Organism tested Effect 
Tropine, n-(4'-ethoxy-carbonyl- 
phenyl-amine-n'-acetyl) 













amine-n'-acetyl)   

























The studied alkaloids have shown gastroprotetive and antiulcer activities, nevertheless many of 
them as senecionine, cocaine, nicotine and LSD have several toxic effects on the body such as 
hepatotoxic, neurotoxic and carcinogenic properties, although some compounds such as morphine 
(hypnoanalgesic) and ephedrine (nasal decongestant) are more effective in other afflictions. 
Consequently many alkaloids are not viable for development as gastroprotective drugs or they would 
need modification of functional groups in their chemical structures for this propose. Nevertheless, they 
can be used as pharmacological tools in pathophysiological understanding of gastrointestinal diseases, 
particulalry peptic ulcers, and in the viability of new active compounds for synthesis of new 
medicines. In this context, it is necessary to support financially the multidisciplinary and 




interdisciplinary research, mostly those related to natural products enabling the discovery of new 
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